PDL BioPharma (PDLI) Misses Q1 EPS by 8c, Miss on Revenues
Tweet
Share
E-mailGet Alerts PDLI Hot Sheet
Price: $2.47 --0%
Financial Fact:
Interest and other expense: -4.51M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Interest and other expense: -4.51M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
PDL BioPharma (NASDAQ: PDLI) reported Q1 EPS of $0.01, $0.08 worse than the analyst estimate of $0.09. Revenue for the quarter came in at $38.5 million versus the consensus estimate of $56.9 million.
For earnings history and earnings-related data on PDL BioPharma (PDLI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Reading (RDI) Tops Q2 EPS by 4c
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
